Import/Export Declaration for List I and List II Chemicals

Forms and Documents

Document	Type	Status	Availability
1117-0023 NEW Supporting Statement 11_08_2023.docx	Supporting Statement A	Uploaded 2023-11-22	Repair queued
0023 30 day FRN.pdf	Supplementary Document	Uploaded 2023-11-16	Repair queued
0023_60 Day FRN.pdf	Supplementary Document	Uploaded 2023-11-16	Repair queued
Create Screenshot New DEA 486a (Import).pdf	Supplementary Document	Uploaded 2017-06-16	Repair queued
Create Screenshot New DEA 486a (Import).pdf	Supplementary Document	Uploaded 2017-06-16	Repair queued
21 U.S.C. 830.doc	Supplementary Document	Uploaded 2008-11-20	Repair queued

IC Document Collections

IC ID	Collection	Type	Status	Form
12323	Import/Export Declaration for List I and List II Chemicals (Year)	Other-DEA 486 (Export) Web Application	Modified

ICR Details

OMB Control No: 1117-0023	ICR Reference No: 202311-1117-004
Status: Received in OIRA	Previous ICR Reference No: 202008-1117-004
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: Import/Export Declaration for List I and List II Chemicals
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 11/29/2023

	Requested	Previously Approved
Expiration Date	36 Months From Approved	12/31/2023
Responses	21,538	16,416
Time Burden (Hours)	4,211	4,840
Cost Burden (Dollars)	0	313,919

---

Abstract: The DEA import/export declarations (DEA Forms 486 and 486A), will be replaced with an electronic process. Upon receipt of a complete declaration through the Diversion Control Division secure network application, DEA will provide the importer or exporter with the notice of receipt that must then be filed with Custom Border Patrol (CBP) as part of the CBP import or export filing through Automated Commercial Environment (ACE), or any successor system. DEA will also transmit the declaration information electronically to CBP so that customs officers can validate importations and exportations subject to DEA regulations. Because of the requirement that regulated persons submit reports of regulated transactions in Listed chemicals to the DEA, the DEA is requiring such domestic regulated transaction reports to be submitted through the DEA Diversion Control Division secure network application, in addition to import and export regulated transactions. Mandatory reporting requirements for domestic regulated transactions are included as part of this rule because it allows for the DEA to create, at one time, an efficient, streamlined reporting structure of regulated activities applicable to tableting and encapsulating machines. As part of the implementation of the International Trade Data System (ITDS), the DEA is mandating electronic filing of return information for any person who desires to import non-narcotic substances in schedules III, IV, and V or to export non-narcotic substances in schedules III and IV and any other substance in schedule V, to furnish a controlled substances import declaration/controlled substance export invoice on DEA Forms 486 and 486A

---

Authorizing Statute(s): US Code: 21 USC 971 Name of Law: ...importation and exportation of listed chemicals
  

Citations for New Statutory Requirements: PL: Pub.L. 109 - 177 721 Name of Law: Combat Methamphetamine Act

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	88 FR 62396	09/11/2023
30-day Notice:	Federal Register Citation:	Citation Date:
	88 FR 78787	11/16/2023
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Import/Export Declaration for List I and List II Chemicals (Year)	486, 486 (page 2), 486A, 486A (page 2)	Import/Export Declaration for List I and List II Chemicals ,   Import/Export Declaration for List I and List II Chemicals ,   Import Declaration for Ephedrine, Pseudoephedrine, and Phenylpropanolamine ,   Import Declaration for Ephedrine, Pseudoephedrine, and Phenylpropanolamine

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	21,538	16,416	0	5,122	0	0
Annual Time Burden (Hours)	4,211	4,840	0	-629	0	0
Annual Cost Burden (Dollars)	0	313,919	0	-313,919	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: The increase in annual responses, annual burden hours, and annual cost reflect adjustments related to normal business activity. There have been no statutory or regulatory changes affecting this information collection. The table below summarizes the changes since the last renewal of this information collection.

---

Annual Cost to Federal Government: $772,971

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     Yes

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 11/29/2023

---